In GSK Challenge Of Salonpas Claims, NAD Embarks On Review Of Unchartered Argument

'Regulatory Review’ Claim For Salonpas Not A Comparison To Voltaren Approval

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.